Endogenous Ouabain: An Old Cardiotonic Steroid as a New Biomarker of Heart Failure and a Predictor of Mortality after Cardiac Surgery

Marco Simonini, Simona Pozzoli, Elena Bignami, Nunzia Casamassima, Elisabetta Messaggio, Chiara Lanzani, Elena Frati, Irene Maria Botticelli, Francesco Rotatori, Ottavio Alfieri, Alberto Zangrillo, Paolo Manunta

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Cardiovascular diseases remain the main cause of mortality and morbidity worldwide; primary prevention is a priority for physicians. Biomarkers are useful tools able to identify high-risk individuals, guide treatments, and determine prognosis. Our aim is to investigate Endogenous Ouabain (EO), an adrenal stress hormone with hemodynamic effects, as a valuable biomarker of heart failure. In a population of 845 patients undergoing elective cardiac surgery, we have investigated the relationships between EO and echocardiography parameters/plasmatic biomarker of cardiac function. EO was found to be correlated negatively with left ventricular EF (p=0.001), positively with Cardiac End-Diastolic Diameter (p=0.047), and positively with plasmatic NT-proBNP level (p=0.02). Moreover, a different plasmatic EO level (both preoperative and postoperative) was found according to NYHA class (p=0.013). All these results have been replicated on an independent cohort of patients (147 subjects from US). Finally, a higher EO level in the immediate postoperative time was indicative of a more severe cardiological condition and it was associated with increased perioperative mortality risk (p=0.023 for 30-day morality). Our data suggest that preoperative and postoperative plasmatic EO level identifies patients with a more severe cardiovascular presentation at baseline. These patients have a higher risk of morbidity and mortality after cardiac surgery.

Original languageEnglish
Article number714793
JournalBioMed Research International
Volume2015
DOIs
Publication statusPublished - 2015

Fingerprint

Cardiac Glycosides
Biomarkers
Ouabain
Surgery
Thoracic Surgery
Heart Failure
Mortality
Morbidity
Echocardiography
Hemodynamics
Primary Prevention
Cardiovascular Diseases
Hormones
Physicians
Population

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Endogenous Ouabain : An Old Cardiotonic Steroid as a New Biomarker of Heart Failure and a Predictor of Mortality after Cardiac Surgery. / Simonini, Marco; Pozzoli, Simona; Bignami, Elena; Casamassima, Nunzia; Messaggio, Elisabetta; Lanzani, Chiara; Frati, Elena; Botticelli, Irene Maria; Rotatori, Francesco; Alfieri, Ottavio; Zangrillo, Alberto; Manunta, Paolo.

In: BioMed Research International, Vol. 2015, 714793, 2015.

Research output: Contribution to journalArticle

Simonini, Marco ; Pozzoli, Simona ; Bignami, Elena ; Casamassima, Nunzia ; Messaggio, Elisabetta ; Lanzani, Chiara ; Frati, Elena ; Botticelli, Irene Maria ; Rotatori, Francesco ; Alfieri, Ottavio ; Zangrillo, Alberto ; Manunta, Paolo. / Endogenous Ouabain : An Old Cardiotonic Steroid as a New Biomarker of Heart Failure and a Predictor of Mortality after Cardiac Surgery. In: BioMed Research International. 2015 ; Vol. 2015.
@article{52c2522b15cb4a9fb96fc26674d692f5,
title = "Endogenous Ouabain: An Old Cardiotonic Steroid as a New Biomarker of Heart Failure and a Predictor of Mortality after Cardiac Surgery",
abstract = "Cardiovascular diseases remain the main cause of mortality and morbidity worldwide; primary prevention is a priority for physicians. Biomarkers are useful tools able to identify high-risk individuals, guide treatments, and determine prognosis. Our aim is to investigate Endogenous Ouabain (EO), an adrenal stress hormone with hemodynamic effects, as a valuable biomarker of heart failure. In a population of 845 patients undergoing elective cardiac surgery, we have investigated the relationships between EO and echocardiography parameters/plasmatic biomarker of cardiac function. EO was found to be correlated negatively with left ventricular EF (p=0.001), positively with Cardiac End-Diastolic Diameter (p=0.047), and positively with plasmatic NT-proBNP level (p=0.02). Moreover, a different plasmatic EO level (both preoperative and postoperative) was found according to NYHA class (p=0.013). All these results have been replicated on an independent cohort of patients (147 subjects from US). Finally, a higher EO level in the immediate postoperative time was indicative of a more severe cardiological condition and it was associated with increased perioperative mortality risk (p=0.023 for 30-day morality). Our data suggest that preoperative and postoperative plasmatic EO level identifies patients with a more severe cardiovascular presentation at baseline. These patients have a higher risk of morbidity and mortality after cardiac surgery.",
author = "Marco Simonini and Simona Pozzoli and Elena Bignami and Nunzia Casamassima and Elisabetta Messaggio and Chiara Lanzani and Elena Frati and Botticelli, {Irene Maria} and Francesco Rotatori and Ottavio Alfieri and Alberto Zangrillo and Paolo Manunta",
year = "2015",
doi = "10.1155/2015/714793",
language = "English",
volume = "2015",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Endogenous Ouabain

T2 - An Old Cardiotonic Steroid as a New Biomarker of Heart Failure and a Predictor of Mortality after Cardiac Surgery

AU - Simonini, Marco

AU - Pozzoli, Simona

AU - Bignami, Elena

AU - Casamassima, Nunzia

AU - Messaggio, Elisabetta

AU - Lanzani, Chiara

AU - Frati, Elena

AU - Botticelli, Irene Maria

AU - Rotatori, Francesco

AU - Alfieri, Ottavio

AU - Zangrillo, Alberto

AU - Manunta, Paolo

PY - 2015

Y1 - 2015

N2 - Cardiovascular diseases remain the main cause of mortality and morbidity worldwide; primary prevention is a priority for physicians. Biomarkers are useful tools able to identify high-risk individuals, guide treatments, and determine prognosis. Our aim is to investigate Endogenous Ouabain (EO), an adrenal stress hormone with hemodynamic effects, as a valuable biomarker of heart failure. In a population of 845 patients undergoing elective cardiac surgery, we have investigated the relationships between EO and echocardiography parameters/plasmatic biomarker of cardiac function. EO was found to be correlated negatively with left ventricular EF (p=0.001), positively with Cardiac End-Diastolic Diameter (p=0.047), and positively with plasmatic NT-proBNP level (p=0.02). Moreover, a different plasmatic EO level (both preoperative and postoperative) was found according to NYHA class (p=0.013). All these results have been replicated on an independent cohort of patients (147 subjects from US). Finally, a higher EO level in the immediate postoperative time was indicative of a more severe cardiological condition and it was associated with increased perioperative mortality risk (p=0.023 for 30-day morality). Our data suggest that preoperative and postoperative plasmatic EO level identifies patients with a more severe cardiovascular presentation at baseline. These patients have a higher risk of morbidity and mortality after cardiac surgery.

AB - Cardiovascular diseases remain the main cause of mortality and morbidity worldwide; primary prevention is a priority for physicians. Biomarkers are useful tools able to identify high-risk individuals, guide treatments, and determine prognosis. Our aim is to investigate Endogenous Ouabain (EO), an adrenal stress hormone with hemodynamic effects, as a valuable biomarker of heart failure. In a population of 845 patients undergoing elective cardiac surgery, we have investigated the relationships between EO and echocardiography parameters/plasmatic biomarker of cardiac function. EO was found to be correlated negatively with left ventricular EF (p=0.001), positively with Cardiac End-Diastolic Diameter (p=0.047), and positively with plasmatic NT-proBNP level (p=0.02). Moreover, a different plasmatic EO level (both preoperative and postoperative) was found according to NYHA class (p=0.013). All these results have been replicated on an independent cohort of patients (147 subjects from US). Finally, a higher EO level in the immediate postoperative time was indicative of a more severe cardiological condition and it was associated with increased perioperative mortality risk (p=0.023 for 30-day morality). Our data suggest that preoperative and postoperative plasmatic EO level identifies patients with a more severe cardiovascular presentation at baseline. These patients have a higher risk of morbidity and mortality after cardiac surgery.

UR - http://www.scopus.com/inward/record.url?scp=84947262912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947262912&partnerID=8YFLogxK

U2 - 10.1155/2015/714793

DO - 10.1155/2015/714793

M3 - Article

AN - SCOPUS:84947262912

VL - 2015

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 714793

ER -